Results 261 to 270 of about 164,829 (311)
Some of the next articles are maybe not open access.
Liver transplantation in malignant primary hepatic neoplasms
The American Journal of Surgery, 1992Between April 1986 and August 1990, 151 liver transplantations were performed at our institution, 16 (11%) of them in 14 patients with primary hepatic tumors. There were 12 hepatocellular carcinomas, 1 angiosarcoma, and 1 Klatskin tumor. None of the tumors was resectable, and there was no preoperative evidence of extrahepatic tumoral extension ...
Enrique Moreno González +15 more
openaire +2 more sources
Haploidentical Transplants for Myeloproliferative Neoplasms
2017Allogeneic hematopoietic cell transplantation remains the only curative therapy available for patients with myeloproliferative neoplasms and is mostly performed for primary myelofibrosis or secondary myelofibrosis with high dynamic international scoring system-plus score, advanced (or refractory) chronic myelogenous leukemia, and chronic myelomonocytic
Monzr M. Al Malki +2 more
openaire +1 more source
Colorectal and anal neoplasms following liver transplantation
Colorectal Disease, 2010AbstractObjective Liver transplantation (LT) is the treatment of choice for end‐stage liver disease. The required immunosuppression increases the risk for developing malignancies. Some viruses play a crucial role. Data on neoplasms of the colon, rectum and anus in LT are limited.Method A retrospective evaluation of the incidence and clinical course ...
J B, Albright +10 more
openaire +2 more sources
Malignant Neoplasms Occurring After Cardiac Transplantation
JAMA: The Journal of the American Medical Association, 1983Fifty-seven cardiac transplants in 53 patients have been performed; 30 survived for at least three months. Malignant neoplasms developed in three (10%) of these patients. This incidence is more than double that in recipients of donor kidneys at our institution. Kaposi's sarcoma developed in three patients in the combined groups and accounted for 30% of
R P, Lanza +3 more
openaire +3 more sources
[Malignant neoplasms and kidney transplantation].
Der Urologe. Ausg. A, 2010Together with cardiovascular disorders and metabolic changes, malignant diseases are considered as great challenges in clinical transplantation. As far as long-term function of transplanted organs is concerned, an impact of malignancies is obvious. However, it is important to distinguish between neoplastic disease originating from preexisting lesions ...
H, Heynemann +5 more
openaire +1 more source
[Neoplasms in kidney transplant patients].
Actas urologicas espanolas, 1994Our service performed a total of 619 kidney transplants between February 1980 and March 1993. Among them, 41 new neoplasias (6.6%) were diagnosed. Most frequent tumour was epithelioma (25) with a presentation age lower than in the normal population.
J M, Martínez Jabaloyas +6 more
openaire +1 more source
[Neoplasm prevalence in renal transplantation].
Archivos espanoles de urologia, 1997To analyze the prevalence of neoplasms in renal transplant patients and the relative risk for each tumor type according to the immunosuppression regimen.609 renal transplants were reviewed. The risk index was determined by the ratio of the cases observed and predicted.Tumor prevalence was 4.9% (30/609); 6.3% (25/393) were males and 2.3% (5/216) were ...
V, Gómez dos Santos +10 more
openaire +1 more source
[Malignant neoplasms and kidney transplantation].
Actas urologicas espanolas, 1995In 661 renal transplantations, 2 potentially migrated tumours (0.38%), 5 preexisting neoplasias (0.76%), and 31 "de novo" tumours were seen in 29 patients (4.4&). Although of very low incidence, the likelihood of tumour migration from elderly donors, given the circumstances surrounding removal, offers a high risk.
N, Serrallach +9 more
openaire +1 more source
[Neoplasms following kidney transplantation].
Khirurgiia, 1991The incidence, predisposing factors, localization, evolution and outcome of neoplasms following kidney transplantation were studied in two groups of patients--120 and 146 patients for an observation period from 1 to 16 years. In patients with adequate renal function who received immunosuppressive treatment for more than one year (accordingly 78 and 88 ...
openaire +1 more source
Transplantable Mouse Neoplasm Control by Neutron Capture Therapy
Nature, 1967AFTER several years of effort based on the application of the principles of neutron capture therapy, we have empirically evolved a procedure which now can be added to the few effective treatments for established invasive transplantable neoplasms of animals.
L E, Farr, T, Konikowski
openaire +2 more sources

